This activity has been supported by independent medical education grants from Abbott, AbbVie, GE HealthCare, Kyowa Kirin, Medtronic, and Merz.
This activity is also supported by in-kind contributions from Abbott, AbbVie, Ambu, Boston Scientific, Cadwell Industries, Medtronic, Merz, and Supernus.
This course is for movement disorder specialists, neurologists, advanced practice providers, and other healthcare professionals involved in the care of patients with a movement or related disorder.
Educational Objectives
After completing this activity, the participant should be better able to:
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PMD Alliance. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Speakers on the cutting edge. #ATMRD2023
Movement Disorder Specialist
Movement Disorder Specialist
Speakers on the cutting edge. #ATMRD2023
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Director of Clinical Trials
Movement Disorder Specialist
Nurse Practitioner
Director, Memory Disorders Program
Certified Specialty Pharmacist
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Movement Disorder Specialist
Board-Certified Nurse Practitioner
Board-Certified Nurse Practitioner
Board-Certified Physician Assistant
Board-Certified Nurse Practitioner
Board-Certified Physician Assistant
Board-Certified Nurse Practitioner
Board-Certified Physician Assistant
Movement Disorder Specialist
Board-Certified Nurse Practitioner
Board-Certified Nurse Practitioner
Board-Certified Nurse Practitioner
Board-Certified Nurse Practitioner
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.
The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this activity for a maximum of 17.75 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate/Assistant Continuing Medical Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 17.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 17.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com or PMD Alliance at education@pmdalliance.org
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Us: Email – info@pmdalliance.org Tel – 800-256-0966
© 2024, PMD Alliance. All Rights Reserved.